A citation-based method for searching scientific literature

G M Pitari, M D Di Guglielmo, J Park, S Schulz, S A Waldman. Proc Natl Acad Sci U S A 2001
Times Cited: 126

Michael A Valentino, Jieru E Lin, Adam E Snook, Peng Li, Gilbert W Kim, Glen Marszalowicz, Michael S Magee, Terry Hyslop, Stephanie Schulz, Scott A Waldman. J Clin Invest 2011
Times Cited: 99

List of shared articles

Times cited

Guanylyl cyclase C as a biomarker for immunotherapies for the treatment of gastrointestinal malignancies.
John C Flickinger, Jeffrey A Rappaport, Joshua R Barton, Trevor R Baybutt, Amanda M Pattison, Adam E Snook, Scott A Waldman. Biomark Med 2021

An update on guanylyl cyclase C in the diagnosis, chemoprevention, and treatment of colorectal cancer.
Jeffrey A Rappaport, Scott A Waldman. Expert Rev Clin Pharmacol 2020

Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer.
Allison A Aka, Jeff A Rappaport, Amanda M Pattison, Takami Sato, Adam E Snook, Scott A Waldman. Expert Rev Clin Pharmacol 2017

GUCY2C ligand replacement to prevent colorectal cancer.
Erik S Blomain, Amanda M Pattison, Scott A Waldman. Cancer Biol Ther 2016

Effect of guanylate cyclase-C activity on energy and glucose homeostasis.
Denovan P Begg, Kris A Steinbrecher, Joram D Mul, Adam P Chambers, Rohit Kohli, April Haller, Mitchell B Cohen, Stephen C Woods, Randy J Seeley. Diabetes 2014

Natriuretic hormones in brain function.
Anastasia Hodes, David Lichtstein. Front Endocrinol (Lausanne) 2014

GUCY2C: at the intersection of obesity and cancer.
Gilbert W Kim, Jieru E Lin, Scott A Waldman. Trends Endocrinol Metab 2013

Pendrin, a novel transcriptional target of the uroguanylin system.
Julia Rozenfeld, Osnat Tal, Orly Kladnitsky, Lior Adler, Edna Efrati, Stephen L Carrithers, Seth L Alper, Israel Zelikovic. Cell Physiol Biochem 2013

Current understanding of guanylin peptides actions.
Aleksandra Sindic. ISRN Nephrol 2013